This study is consistent with a finding that over-expression of lamin B1 is associated with low grade differentiation in pancreatic cancer and that the drug betulinic acid down-regulates lamin B1 expression as part of its anti-cancer activity [72]. The gene discussed is LMNB1; the disease is pancreatic neoplasm.